Wednesday, September 25, 2013 11:25:18 AM
I agree PhilB1. Aethlon is purposely not updating their website. I believe there will be a lot of changes in the near future.
For the past few years or so we have seen:
ELLSA™ Exosome Assay
"As our focus is directed towards advancing the pipeline of Aethlon ADAPT™ system therapies, we plan to license or sell this technology to an organization already established in the research diagnostics field."
No one jumped on ELLSA then, so why now?
Now recently, there has been a huge direction change with the formal introduction of Exosome Sciences Inc. (Including a new home in Langhorne, Pennsylvania)and two "best-known researchers in the exosome field" now hired by Aethlon.
IMO two "best-known researchers" don't jump over to Aethlon unless they see something big in the works. I also think JJ is slowly leading up to bigger news. We haven't heard much of Exosome Sciences lately and just maybe they have been really busy and have other developments in the works. I don't think it's just ELLSA that caused to major players to make such a big move. again IMO.
For the past few years or so we have seen:
ELLSA™ Exosome Assay
"As our focus is directed towards advancing the pipeline of Aethlon ADAPT™ system therapies, we plan to license or sell this technology to an organization already established in the research diagnostics field."
No one jumped on ELLSA then, so why now?
Now recently, there has been a huge direction change with the formal introduction of Exosome Sciences Inc. (Including a new home in Langhorne, Pennsylvania)and two "best-known researchers in the exosome field" now hired by Aethlon.
IMO two "best-known researchers" don't jump over to Aethlon unless they see something big in the works. I also think JJ is slowly leading up to bigger news. We haven't heard much of Exosome Sciences lately and just maybe they have been really busy and have other developments in the works. I don't think it's just ELLSA that caused to major players to make such a big move. again IMO.
Recent AEMD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:27:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:27:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:27:18 PM
- Advancements in Novel Immunotherapeutics in The Oncology Battle • Newsfile • 03/24/2026 02:30:00 PM
- Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review • PR Newswire (US) • 03/24/2026 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 01:15:09 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities • PR Newswire (US) • 03/12/2026 12:01:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th • GlobeNewswire Inc. • 03/06/2026 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:15:32 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/18/2026 02:54:05 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/18/2026 01:22:47 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 10:10:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 09:15:44 PM
- Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update • PR Newswire (US) • 02/12/2026 09:15:00 PM
- Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026 • PR Newswire (US) • 02/04/2026 01:01:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/27/2026 09:15:36 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/27/2026 09:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2026 10:15:32 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/16/2026 10:14:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/16/2026 09:15:44 PM
